LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19.

Fernández-Ruiz, Mario / Olea, Beatriz / Almendro-Vázquez, Patricia / Giménez, Estela / Marcacuzco, Alberto / San Juan, Rafael / Justo, Iago / Calvo-Pulido, Jorge / García-Sesma, Álvaro / Manrique, Alejandro / Caso, Oscar / Cambra, Félix / Talayero, Paloma / López-Medrano, Francisco / Remigia, María José / Ruiz-Merlo, Tamara / Parra, Patricia / Paz-Artal, Estela / Jiménez, Carlos /
Loinaz, Carmelo / Navarro, David / Laguna-Goya, Rocío / Aguado, José M

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

2021  Volume 21, Issue 8, Page(s) 2785–2794

Abstract: ... cell-mediated immunity (SARS-CoV-2-CMI) after liver transplantation (LT) remains unknown. We included 31 LT recipients ... time from diagnosis. Post-transplant SARS-CoV-2-CMI was detected by ICS in 90.3% (28/31) of recipients ... assay after a median of 103 days from COVID-19 diagnosis. Serum SARS-CoV-2 IgG antibodies were measured ...

Abstract Whether immunosuppression impairs severe acute respiratory syndrome coronavirus 2-specific T cell-mediated immunity (SARS-CoV-2-CMI) after liver transplantation (LT) remains unknown. We included 31 LT recipients in whom SARS-CoV-2-CMI was assessed by intracellular cytokine staining (ICS) and interferon (IFN)-γ FluoroSpot assay after a median of 103 days from COVID-19 diagnosis. Serum SARS-CoV-2 IgG antibodies were measured by ELISA. A control group of nontransplant immunocompetent patients were matched (1:1 ratio) by age and time from diagnosis. Post-transplant SARS-CoV-2-CMI was detected by ICS in 90.3% (28/31) of recipients, with higher proportions for IFN-γ-producing CD4
MeSH term(s) Antibodies, Viral ; COVID-19 ; COVID-19 Testing ; Humans ; Liver Transplantation/adverse effects ; SARS-CoV-2 ; T-Lymphocytes ; Transplant Recipients
Chemical Substances Antibodies, Viral
Language English
Publishing date 2021-06-25
Publishing country United States
Document type Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 2060594-8
ISSN 1600-6143 ; 1600-6135
ISSN (online) 1600-6143
ISSN 1600-6135
DOI 10.1111/ajt.16708
Shelf mark
Zs.A 5542: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top